Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0002042266-25-000003

Director sold 4,000,000 shares at $2.15 ($8,600,000)

From the SEC's structured data for this filing

Trades in this filing

Foundation Fighting Blindness Retinal Degeneration Fund · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-09 Sale : show line 1 in the form −4,000,000 $2.15 $8,600,000 5,492,171 D
Open-market sales · 4,000,000 sh · avg $2.15 · $8,600,000
Loading xslF345X05/primary_doc.xml…